HQL Abrdn Life Sciences Investors

17.56USD0.00%Mkt Cap: 533.97M $P/E: 2.64

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the…

Key Statistics

Company
Market Cap533.97M USD
Enterprise Value533.11M USD
Revenue (TTM)1.11M USD
Gross Profit1.11M USD
Net Income (TTM)85.59M USD
Revenue/Share0.04 USD
Last Price17.56 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees—
CountryUS
SectorFinancial Services
IndustryAsset Management
ISIN—
Valuation
P/E (Trailing)2.64
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue480.39
P/S481.16
P/B0.95
EPS (TTM)6.64
EPS (Forward)—
52W Range
15.6028% of range22.67
52W High22.67 USD
52W Low15.60 USD
Profitability
Gross Margin100.00%
Oper. Margin-516.53%
EBITDA Margin0.00%
Profit Margin99.08%
ROE16.66%
ROA16.61%
Growth
Revenue Growth-60.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF31.71M USD
CapEx (TTM)—
FCF Margin-392.20%
FCF Yield-0.82%
Net Debt-851.60K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio1.61
Quick Ratio1.55
Book Value/Sh18.44 USD
Cash/Share0.03 USD
Dividends
Fwd Div Rate2.24 USD
Trail. Div Rate1.91 USD
Div. Yield12.67%
5Y Avg Yield10.59%
Payout Ratio28.77%
Ex-Div DateAug 24, 2026
Pay DateDec 31, 2018
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.30.41M
Float—
Insiders0.00%
Institutions26.77%
Short Interest
Short Ratio0.5d
Short % Out.0.22%
Shares Short67.42K
Short (prev mo.)58.63K
Technical
SMA 5020.16 (-12.9%)
SMA 20018.17 (-3.3%)
Beta0.73
S&P 52W Chg15.78%
Avg Vol (30d)130.98K
Avg Vol (10d)133.49K
Technical Indicators
RSI (14)25.2
MACD-0.7097
MACD Signal-0.5468
MACD Hist.-0.1629
BB Upper20.61 USD
BB Middle18.96 USD
BB Lower17.30 USD
BB Width17.46%
ATR (14)0.5527 USD
Vol Ratio (20d)0.70x